These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9683292)

  • 1. Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity.
    Chinol M; Casalini P; Maggiolo M; Canevari S; Omodeo ES; Caliceti P; Veronese FM; Cremonesi M; Chiolerio F; Nardone E; Siccardi AG; Paganelli G
    Br J Cancer; 1998 Jul; 78(2):189-97. PubMed ID: 9683292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of active site protected poly(ethylene glycol)-avidin bioconjugates.
    Salmaso S; Semenzato A; Bersania S; Chinol M; Paganelli G; Caliceti P
    Biochim Biophys Acta; 2005 Oct; 1726(1):57-66. PubMed ID: 15964691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ethylene glycol)-avidin bioconjugates: suitable candidates for tumor pretargeting.
    Caliceti P; Chinol M; Roldo M; Veronese FM; Semenzato A; Salmaso S; Paganelli G
    J Control Release; 2002 Sep; 83(1):97-108. PubMed ID: 12220842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptavidin in antibody pretargeting. 3. Comparison of biotin binding and tissue localization of 1,2-cyclohexanedione and succinic anhydride modified recombinant streptavidin.
    Wilbur DS; Hamlin DK; Meyer DL; Mallett RW; Quinn J; Vessella RL; Press OW
    Bioconjug Chem; 2002; 13(3):611-20. PubMed ID: 12009953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue distribution of avidin and streptavidin injected to mice. Effect of avidin carbohydrate, streptavidin truncation and exogenous biotin.
    Schechter B; Silberman R; Arnon R; Wilchek M
    Eur J Biochem; 1990 Apr; 189(2):327-31. PubMed ID: 2186907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
    Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA
    Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of [3H]biotin bound to different avidin analogues.
    Kang YS; Saito Y; Pardridge WM
    J Drug Target; 1995; 3(2):159-65. PubMed ID: 7496729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PEGylation and immune complex formation on the pharmacokinetics and biodistribution of recombinant interleukin 10 in mice.
    Alvarez HM; So OY; Hsieh S; Shinsky-Bjorde N; Ma H; Song Y; Pang Y; Marian M; Escandón E
    Drug Metab Dispos; 2012 Feb; 40(2):360-73. PubMed ID: 22083830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenografts.
    Deckert PM; Jungbluth A; Montalto N; Clark MA; Finn RD; Williams C; Richards EC; Panageas KS; Old LJ; Welt S
    Int J Cancer; 2000 Aug; 87(3):382-90. PubMed ID: 10897044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical modification of streptavidin and avidin: in vitro and in vivo analysis.
    Rosebrough SF; Hartley DF
    J Nucl Med; 1996 Aug; 37(8):1380-4. PubMed ID: 8708779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin and biotin.
    Rosebrough SF
    Nucl Med Biol; 1993 Jul; 20(5):663-8. PubMed ID: 8358353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation.
    Sun X; Yang Z; Li S; Tan Y; Zhang N; Wang X; Yagi S; Yoshioka T; Takimoto A; Mitsushima K; Suginaka A; Frenkel EP; Hoffman RM
    Cancer Res; 2003 Dec; 63(23):8377-83. PubMed ID: 14678999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermolecular interaction of avidin and PEGylated biotin.
    Ke S; Wright JC; Kwon GS
    Bioconjug Chem; 2007; 18(6):2109-14. PubMed ID: 17944528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
    Goodwin DA; Meares CF; Osen M
    J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody.
    Marshall D; Pedley RB; Boden JA; Boden R; Melton RG; Begent RH
    Br J Cancer; 1996 Mar; 73(5):565-72. PubMed ID: 8605088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of poultry egg-white avidins and their potential as a tool in pretargeting cancer treatment.
    Hytönen VP; Laitinen OH; Grapputo A; Kettunen A; Savolainen J; Kalkkinen N; Marttila AT; Nordlund HR; Nyholm TK; Paganelli G; Kulomaa MS
    Biochem J; 2003 May; 372(Pt 1):219-25. PubMed ID: 12558501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates.
    Yang Z; Wang J; Lu Q; Xu J; Kobayashi Y; Takakura T; Takimoto A; Yoshioka T; Lian C; Chen C; Zhang D; Zhang Y; Li S; Sun X; Tan Y; Yagi S; Frenkel EP; Hoffman RM
    Cancer Res; 2004 Sep; 64(18):6673-8. PubMed ID: 15374983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical and pharmacokinetic characterization of highly potent recombinant L-methionine gamma-lyase conjugated with polyethylene glycol as an antitumor agent.
    Takakura T; Takimoto A; Notsu Y; Yoshida H; Ito T; Nagatome H; Ohno M; Kobayashi Y; Yoshioka T; Inagaki K; Yagi S; Hoffman RM; Esaki N
    Cancer Res; 2006 Mar; 66(5):2807-14. PubMed ID: 16510603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretargeting of necrotic tumors with biotinylated hypericin using 123I-labeled avidin: evaluation of a two-step strategy.
    Marysael T; Bauwens M; Ni Y; Bormans G; Rozenski J; de Witte P
    Invest New Drugs; 2012 Dec; 30(6):2132-40. PubMed ID: 22187204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.